Cancer Research Technology
Log in Register
Menu

Anti-O-linked N-acetylglucosamine (O-GlcNAc) [14D9.D4]
RECENTLY UPDATED

Invented at University of Georgia

Info

Catalogue Number 153888
Applications
RECENTLY UPDATED
ELISA WB
Antigen/Gene or Protein Targets
RECENTLY UPDATED
O-linked N-acetylglucosamine
Synonyms
RECENTLY UPDATED
O-GlcNAc
Reactivity
RECENTLY UPDATED
Mammals
Relevance
RECENTLY UPDATED
The study of O-GlcNAc, a ubiquitous translation and transcription regulator which is found in a wide variety of proteins, is of great relevance to multiple chronic human and veterinary diseases. These include diabetes (and its effects in the heart, kidneys and eyes), cardiovascular disease, neurodegenerative disorders involving both plaque and tangle formation, inflammatory processes, liver disease, fibrosis, metabolic disorders and cancer. There is fast growing collection of evidence that O-GlcNAcylation plays a pivotal role in epigenetics.
Host
RECENTLY UPDATED
Mouse
Immunogen
RECENTLY UPDATED
Synthetic peptide O-GlcNAc
Subclass
RECENTLY UPDATED
IgG2a
Notes
RECENTLY UPDATED
This a 23 Mab panel was developed specifically to study the diverse roles of O-GlcNAc and that can be employed for detection, isolation, and site localization. For details on antigen strategy, please consult: Chin Fen Teo, et al., Nat Chem Biol. 2010 May; 6(5): 338-343. doi:10.1038/nchembio.338.
Research Area
RECENTLY UPDATED
Cell Signaling & Signal Transduction, Metabolism, Cancer, Epigenetics & Nuclear Signalling, Gene Expression, Neurobiology

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries
RECENTLY UPDATED

20305658

26822118


Add a reference

References: 2 entries
RECENTLY UPDATED

20305658

26822118


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor